| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 First and
2 Second Divisions of Internal Medicine and
3 Surgery Department, University Hospital of Palermo, 90127 Palermo, Italy.
aAddress correspondence to this author at: via Coffaro 25, 90124 Palermo, Italy. Fax 39-091-6552936; e-mail liwcar{at}tin.it.
Background: Most studies of anti-transglutaminase (anti-tTG) assays have considered preselected groups of patients. This study compared the sensitivity, specificity, and predictive value of an immunofluorescence method for anti-endomysial antibodies (EmAs) and two anti-tTG ELISAs, one using guinea pig tTG (gp-tTG) and the other human tTG (h-tTG) as antigen, in consecutive patients investigated for suspected celiac disease (CD).
Methods: We studied 207 consecutive patients (99 men, 108 women; age range, 17–84 years) who underwent intestinal biopsy for suspected CD. Patients presented with one or more of the following: weight loss, anemia, chronic diarrhea, abdominal pain, dyspepsia, alternating bowel habits, constipation, pain in the joints, and dermatitis. At entry to the study, an intestinal biopsy was performed and a serum sample was taken for IgA EmAs, anti-gp-tTG, and anti-h-tTG.
Results: Intestinal histology showed that 24 patients had partial or total villous atrophy; in these patients the diagnosis of CD was confirmed by follow-up. The remaining 183 patients had villous/crypt ratios that were within our laboratory’s reference values and were considered controls. Serum EmAs, anti-gp-tTG, and anti-h-tTG were positive in all 24 CD patients; in the control group, none were positive for serum EmAs, but 15 of 183 (8.2%) were positive for anti-gp-tTG, and 6 of 183 (3.3%) were positive for anti-h-tTG. Sensitivity was 100% for all assays, whereas specificity was 100% for the EmA, 92% for the anti-gp-tTG, and 97% for the anti-h-tTG assay. The negative predictive value was 100% for all assays; the positive predictive value was 100% for the EmA, 80% [95% confidence interval (CI), 65–95%] for the anti-h-tTG (P = 0.03 vs EmA) and 60% (95% CI, 44–76%) for the anti-gp-tTG assay (P = 0.0002 vs EmA). Areas (95% CIs) under the ROC curves were 0.987 (0.97–1.0) for anti-h-tTG and 0.965 (0.94–0.99) for anti-gp-tTG. Most of the patients testing false positive for anti-tTG had Crohn disease or chronic liver disease.
Conclusions: Although both anti-tTG ELISAs showed optimum sensitivity, their lack of specificity yielded positive predictive values significantly lower than those for the EmA assay.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  D. Basso, G. Guariso, P. Fogar, A. Meneghel, C.-F. Zambon, F. Navaglia, E. Greco, S. Schiavon, M. Rugge, and M. Plebani Antibodies against Synthetic Deamidated Gliadin Peptides for Celiac Disease Diagnosis and Follow-Up in Children Clin. Chem., January 1, 2009; 55(1): 150 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Rashtak and J. A. Murray Tailored Testing for Celiac Disease Ann Intern Med, September 4, 2007; 147(5): 339 - 341. [Full Text] [PDF]
|
|
|
|
|
|
A. Carroccio, L. Di Prima, G. Pirrone, C. Scalici, A. M. Florena, M. Gasparin, G. Tolazzi, A. Gucciardi, C. Sciume, and G. Iacono Anti-Transglutaminase Antibody Assay of the Culture Medium of Intestinal Biopsy Specimens Can Improve the Accuracy of Celiac Disease Diagnosis Clin. Chem., June 1, 2006; 52(6): 1175 - 1180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Zintzaras and A. E. Germenis Performance of Antibodies against Tissue Transglutaminase for the Diagnosis of Celiac Disease: Meta-Analysis Clin. Vaccine Immunol., February 1, 2006; 13(2): 187 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. E. Prince Evaluation of the INOVA Diagnostics Enzyme-Linked Immunosorbent Assay Kits for Measuring Serum Immunoglobulin G (IgG) and IgA to Deamidated Gliadin Peptides Clin. Vaccine Immunol., January 1, 2006; 13(1): 150 - 151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Carroccio, I. Brusca, G. Iacono, L. Di Prima, S. Teresi, G. Pirrone, A. M. Florena, S. M. La Chiusa, and M. R. Averna Anti-Actin Antibodies in Celiac Disease: Correlation with Intestinal Mucosa Damage and Comparison of ELISA with the Immunofluorescence Assay Clin. Chem., May 1, 2005; 51(5): 917 - 920. [Full Text] [PDF]
|
|
|
|
|
|
I. Dahlbom, M. Olsson, N. K. Forooz, A. G. Sjoholm, L. Truedsson, and T. Hansson Immunoglobulin G (IgG) Anti-Tissue Transglutaminase Antibodies Used as Markers for IgA-Deficient Celiac Disease Patients Clin. Vaccine Immunol., February 1, 2005; 12(2): 254 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Van Meensel, M. Hiele, I. Hoffman, S. Vermeire, P. Rutgeerts, K. Geboes, and X. Bossuyt Diagnostic Accuracy of Ten Second-Generation (Human) Tissue Transglutaminase Antibody Assays in Celiac Disease Clin. Chem., November 1, 2004; 50(11): 2125 - 2135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Baldas, T. Not, A. Tommasini, F. Ansaldi, S. Demarini, D. Sblattero, R. Marzari, L. Torelli, A. Burlina, C. Tiribelli, et al. Anti-Transglutaminase Antibodies and Age Clin. Chem., October 1, 2004; 50(10): 1856 - 1860. [Full Text] [PDF]
|
|
|
|
 |
|
 J.-J. Baudon, C. Johanet, Y. B. Absalon, G. Morgant, S. Cabrol, and J.-F. Mougenot Diagnosing Celiac Disease: A Comparison of Human Tissue Transglutaminase Antibodies With Antigliadin and Antiendomysium Antibodies Arch Pediatr Adolesc Med, June 1, 2004; 158(6): 584 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Lumbreras-Lacarra, J. M. Ramos-Rincon, and I. Hernandez-Aguado Methodology in Diagnostic Laboratory Test Research in Clinical Chemistry and Clinical Chemistry and Laboratory Medicine Clin. Chem., March 1, 2004; 50(3): 530 - 536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A A Fisher, M W Davis, and M M Budge Should we screen adults with osteoporotic fractures for coeliac disease? Gut, January 1, 2004; 53(1): 154 - 155. [Full Text]
|
|
|
|
|
|
A. Picarelli, M. Di Tola, L. Sabbatella, S. Vetrano, M. C. Anania, A. Spadaro, M. L. Sorgi, and E. Taccari Anti-Tissue Transglutaminase Antibodies in Arthritic Patients: A Disease-specific Finding? Clin. Chem., December 1, 2003; 49(12): 2091 - 2094. [Full Text] [PDF]
|
|
|
|
|
|
A. Carroccio, G. Iacono, M. Cottone, L. Di Prima, F. Cartabellotta, F. Cavataio, C. Scalici, G. Montalto, G. Di Fede, G. Rini, et al. Diagnostic Accuracy of Fecal Calprotectin Assay in Distinguishing Organic Causes of Chronic Diarrhea from Irritable Bowel Syndrome: A Prospective Study in Adults and Children Clin. Chem., June 1, 2003; 49(6): 861 - 867. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
